Loading...

Cochlear Limited

CHEOY•PNK
Healthcare
Medical - Devices
$61.26
$0.05(0.08%)
U.S. Market opens in 5h 1m

Cochlear Limited (CHEOY) Stock Overview

Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.1B
P/E Ratio33.05
EPS (TTM)$1.87
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$66.69
3 Months$75.39
1 Year Target$83.40

CHEOY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cochlear Limited (CHEOY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $83.40.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.05 and a market capitalization of 8.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.08%
5-Day Change
-3.89%
1-Month Change
7.004%
3-Month Change
-32.17%
6-Month Change
-34.82%
Year-to-Date (YTD) Change
-29.12%
1-Year Change
-25.27%
3-Year Change
-26.65%
5-Year Change
-27.40%
All-Time (Max) Change
111.24%

Contact Information

https://www.cochlear.com
61 2 9428 6555
1 University Avenue, Sydney, NSW, 2109

Company Facts

4,996 Employees
IPO DateApr 5, 2010
CountryAU
Actively Trading

Frequently Asked Questions